Mycobacteria infect different cell types in the human lung and cause species dependent cellular changes in infected cells.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 26803467)

Published in BMC Pulm Med on January 23, 2016

Authors

Dariimaa Ganbat1,2, Sophie Seehase3,4, Elvira Richter5,6, Ekkehard Vollmer7,8, Norbert Reiling9, Kurt Fellenberg10, Karoline I Gaede11,12, Christian Kugler13,14, Torsten Goldmann15,16

Author Affiliations

1: Clinical and Experimental Pathology, Research Center Borstel, Borstel, Germany. amirad_mon@yahoo.com.
2: Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia. amirad_mon@yahoo.com.
3: Clinical and Experimental Pathology, Research Center Borstel, Borstel, Germany. sseehase@fz-borstel.de.
4: Airway Research Center North (ARCN), Member of the German Center for Lung Research, Gießen, Germany. sseehase@fz-borstel.de.
5: National Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany. elvira.richter@labor-limbach.de.
6: Present address: Labor Limbach, Heidelberg, Germany. elvira.richter@labor-limbach.de.
7: Clinical and Experimental Pathology, Research Center Borstel, Borstel, Germany. evollmer@fz-borstel.de.
8: Airway Research Center North (ARCN), Member of the German Center for Lung Research, Gießen, Germany. evollmer@fz-borstel.de.
9: Microbial Interface Biology, Research Center Borstel, Borstel, Germany. nreiling@fz-borstel.de.
10: Bioinformatics, Research Center Borstel, Borstel, Germany. kfellenberg@fz-borstel.de.
11: Clinical and Experimental Pathology, Research Center Borstel, Borstel, Germany. kgaede@fz-borstel.de.
12: Airway Research Center North (ARCN), Member of the German Center for Lung Research, Gießen, Germany. kgaede@fz-borstel.de.
13: Airway Research Center North (ARCN), Member of the German Center for Lung Research, Gießen, Germany. C.Kugler@lungenclinic.de.
14: Thoracic Surgery, Lungen Clinic Grosshansdorf, Grosshansdorf, Germany. C.Kugler@lungenclinic.de.
15: Clinical and Experimental Pathology, Research Center Borstel, Borstel, Germany. tgoldmann@fz-borstel.de.
16: Airway Research Center North (ARCN), Member of the German Center for Lung Research, Gießen, Germany. tgoldmann@fz-borstel.de.

Articles cited by this

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med (2007) 33.18

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med (1992) 10.08

Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol (2008) 5.03

Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis (2008) 4.14

The immune response in tuberculosis. Annu Rev Immunol (2013) 3.91

The multiplication of tubercle bacilli within normal phagocytes in tissue culture. J Exp Med (1952) 3.65

Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med (1990) 3.38

The growth of tubercle bacilli in monocytes from normal and vaccinated rabbits. Am Rev Tuberc (1954) 3.26

Correspondence analysis applied to microarray data. Proc Natl Acad Sci U S A (2001) 3.19

Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol (2000) 3.19

Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol (2000) 3.14

Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect Immun (1996) 3.11

Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science (2002) 3.01

Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med (2000) 2.97

Growth characteristics of tubercle bacilli and certain other mycobacteria in HeLa cells. J Exp Med (1957) 2.86

IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol (2007) 2.75

Cell biology of mycobacterium tuberculosis phagosome. Annu Rev Cell Dev Biol (2004) 2.75

Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J Infect Dis (1990) 2.66

Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect (2006) 2.65

Secretion of interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines. Eur J Immunol (1992) 2.52

Neutrophil kinetics in health and disease. Trends Immunol (2010) 2.47

Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot. Proc Natl Acad Sci U S A (1990) 2.46

Capacity of human neutrophils to kill Mycobacterium tuberculosis. J Infect Dis (1987) 2.43

Macrophage receptors for Mycobacterium tuberculosis. Infect Immun (1998) 2.42

Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J Clin Invest (1993) 2.38

Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest (2007) 2.38

Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res (1980) 2.34

Multiplication of Mycobacterium tuberculosis Within Normal and "Immune" Mouse Macrophages Cultivated With and Without Streptomycin. Infect Immun (1970) 2.31

Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol (2006) 2.22

Preliminary demonstration of human tuberculoimmunity in vitro. Infect Immun (1981) 2.08

1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun (1998) 1.96

Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe (2012) 1.94

Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax (2009) 1.91

HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. Pathol Res Pract (2001) 1.83

Macrophage apoptosis in tuberculosis. Yonsei Med J (2009) 1.62

Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol (2003) 1.61

Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. J Innate Immun (2010) 1.57

The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells. Infect Immun (2002) 1.51

Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis (2003) 1.41

ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J Immunol (2000) 1.38

The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages. Cell Immunol (1999) 1.34

CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect Immun (1995) 1.33

Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils. Infect Immun (2002) 1.31

Animal models of tuberculosis. Tuberculosis (Edinb) (2005) 1.13

Inhibition of virulent Mycobacterium tuberculosis by murine peritoneal macrophages and human alveolar lavage cells: the effects of lymphokines and recombinant gamma interferon. Tubercle (1986) 1.12

Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. J Infect Dis (1998) 1.11

Roles of calcium and annexins in phagocytosis and elimination of an attenuated strain of Mycobacterium tuberculosis in human neutrophils. Microb Pathog (1998) 1.10

Regulation of human neutrophil apoptosis and lifespan in health and disease. J Cell Death (2014) 1.08

Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8(+) T lymphocytes. J Infect Dis (2002) 1.08

Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo. J Infect Dis (2004) 1.03

Apoptotic cell death kinetics in vitro depend on the cell types and the inducers used. Apoptosis (2004) 1.01

The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae. Respir Res (2010) 1.00

Modulation of the inflammatory response to Streptococcus pneumoniae in a model of acute lung tissue infection. Am J Respir Cell Mol Biol (2008) 0.98

Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection. FEMS Immunol Med Microbiol (2004) 0.98

A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy. Respir Res (2007) 0.93

Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells. Cytokine (2000) 0.90

Nitric oxide not apoptosis mediates differential killing of Mycobacterium bovis in bovine macrophages. PLoS One (2013) 0.88

Mycobacterial persistence and immunity. Front Biosci (2002) 0.88

Effect of stimulation of human macrophages on intracellular survival of Mycobacterium bovis Bacillus Calmette-Guerin. Evaluation with a mycobacterial reporter strain. Am J Respir Crit Care Med (1999) 0.88

Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosis. Tuberculosis (Edinb) (2009) 0.84

Human lung tissue explants reveal novel interactions during Legionella pneumophila infections. Infect Immun (2013) 0.84

Role of mycobacteria-induced monocyte/macrophage apoptosis in the pathogenesis of human tuberculosis. Int J Tuberc Lung Dis (2005) 0.83

Cancer cell necrosis by autoschizis: synergism of antitumor activity of vitamin C: vitamin K3 on human bladder carcinoma T24 cells. Scanning (1998) 0.83

Development of an ex vivo porcine lung model for studying growth, virulence, and signaling of Pseudomonas aeruginosa. Infect Immun (2014) 0.82

Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue. Eur Respir J (2012) 0.80

In vitro infection of human cells with Mycobacterium tuberculosis. Tuberculosis (Edinb) (2012) 0.79

Growth of Mycobacterium bovis, Bacille Calmette-Guérin, within human monocytes-macrophages cultured in serum-free medium. J Immunol Methods (1999) 0.78

HOPE-fixation of lung tissue allows retrospective proteome and phosphoproteome studies. J Proteome Res (2014) 0.78

Intracellular growth of Mycobacterium avium subspecies and global transcriptional responses in human macrophages after infection. BMC Genomics (2014) 0.76

A comparative ultrastructural study of a new type of autoschizis versus a survival cellular mechanism that involves cell membranes of cerebral arteries in humans. Ultrastruct Pathol (2012) 0.76

Isolation and purification of Mycobacterium tuberculosis from H37Rv infected guinea pig lungs. Tuberculosis (Edinb) (2014) 0.76

Autoschizis: another cell death for cancer cells induced by oxidative stress. Ital J Anat Embryol (2001) 0.76

Fate of Mycobacterium tuberculosis in peroxidase-loaded resting murine macrophages. Int J Mycobacteriol (2012) 0.76